# Verrica Pharmaceuticals Inc.: Form 8-K, filed Dec 30, 2025

- Company: [Verrica Pharmaceuticals Inc.](/companies/vrca.md) (CIK 1660334)
- Form: 8-K
- Filed: 2025-12-30
- Accepted by EDGAR: Dec 30, 2025, 06:05 ET
- Period: 2025-12-23
- Accession: 0001193125-25-335824
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660334/000119312525335824/d54232d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660334/000119312525335824/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660334/000119312525335824/d54232d8k.htm

Filed Dec 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-335824. Last ingested by Listed: Nov 14, 2026, 20:18 ET. No prices; not investment advice.
